We are live on ! Find out more
RMTI icon

Rockwell Medical

36 hedge funds and large institutions have $4.03M invested in Rockwell Medical in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

0.75% less ownership

Funds ownership: 1.72%0.97% (-0.75%)

12% less funds holding

Funds holding: 4136 (-5)

19% less capital invested

Capital invested by funds: $5M → $4.03M (-$970K)

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

Holders
36
Holders Change
-5
Holders Change %
-12.2%
% of All Funds
0.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
9
Reduced
8
Closed
9
Calls
$70K
Puts
Net Calls
+$70K
Net Calls Change
-$21K

RMTI Hedge Fund Activity: Q3 2025 in Review

36 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Rockwell Medical (RMTI) for Q3 2025, worth a combined $4.03M — down 19% from $5M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of RMTI and 4 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 9 added.

The largest buyer was Vanguard Group, adding an estimated $182K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.82M sold.

  • 36 institutional investors held Rockwell Medical (RMTI) as of Q3 2025, down from 41 in Q2 2025.
  • Funds reported $4.03M of Rockwell Medical stock for Q3 2025, down 19% quarter-over-quarter.
  • 4 funds opened new Rockwell Medical positions in Q3 2025 and 9 closed out, a net change of -5 holders.
  • The largest Rockwell Medical buyer in Q3 2025 was Vanguard Group, an estimated $182K added.
  • The largest Rockwell Medical seller in Q3 2025 was Armistice Capital, an estimated $1.82M sold.

Based on aggregated 13F filings for Q3 2025.